# Remaining work and evidence limits

## Experimental phase

Closed. No further training, inference, benchmarking, hardware testing, data collection, or attempts to finish missing runs were performed for the final audit. Incomplete items are recorded below as limitations rather than tasks silently carried into this report.

## Unresolved research coverage

- Strict completion remains 0/50 under the original criterion; see `FINAL_COMPLETION_MATRIX.md` for detailed statuses.
- Many of the 15 planned local LLM configurations were not evaluated with full-corpus and standardized benchmark protocols. Six full WikiText-2 checkpoint evaluations and the separate Pythia results do not satisfy that broader scope.
- The five original RL algorithms have saved curves, but finite seeds, task coverage, protocol details, budget overshoot, and recorded statuses constrain comparison. PPO-Pendulum is an extension, not an original objective.
- The compact transformer is a custom three-layer, width-96 proxy; SSL implementations are task adaptations. They should not be represented as canonical benchmark reproductions.
- Literature field coverage includes 104 uncertain values. Existing primary-source spot checks do not replace complete field-by-field human verification.
- Energy and measured accelerator compute are unavailable or incomplete. Logged wall time has at least one unexplained 1,122.16-second ResNet interval.

## Audit artifacts now available

The final repository includes a rebuilt canonical index and statistics, paired marginal-gain table, full CSV inventory, data-quality register, 19 PNG/SVG figure pairs with catalogue, final Markdown/PDF report, literature validation report, and reproducibility workflow. These outputs make the existing evidence reviewable; they do not fill any experimental gap.

## Conclusions that remain unsupported

The current observations do not establish universal diminishing returns, cross-model causal efficiency, an overall “accuracy per compute” ranking, or generalization beyond the recorded tasks and protocols. Further evidence would require a separately authorized and preregistered study.
